Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Trial of Erlotinib (Tarceva) in Primary Sclerosing Cholangitis With Trisomy 7

NCT00955149 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00955149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Trial of Erlotinib (Tarceva) in Primary Sclerosing Cholangitis With Trisomy 7
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2009
Completion date
April 30, 2013
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoprevention, cholangiocarcinoma, primary sclerosing cholangitis, trisomy 7